TY - JOUR
T1 - Inhibitory actions of δ1-, δ2-, and μ-opioid receptor agonists on excitatory transmission in lamina II neurons of adult rat spinal cord
AU - Glaum, Steven R.
AU - Miller, Richard J.
AU - Hammond, Donna L.
PY - 1994/8
Y1 - 1994/8
N2 - This study examined the electrophysiological consequences of selective activation of δ1-, δ2-, or μ-opioid receptors using whole-cell recordings made from visually identified lamina II neurons in thin transverse slices of young adult rat lumbar spinal cord. Excitatory postsynaptic currents (EPSCs) or potentials (EPSPs) were evoked electrically at the ipsilateral dorsal root entry zone after blocking inhibitory inputs with bicuculline and strychnine, and NMDA receptors with D-2-amino-5- phosphonopentanoic acid. Bath application of the μ receptor agonist [D- Ala2, N-MePhe4, Gly5-ol]enkephalin (DAMGO) or the δ1 receptor agonist [D-Pen2, D-Pen5]enkephalin (DPDPE) produced a log-linear, concentration- dependent reduction in the amplitude of the evoked EPSP/EPSC. By comparison, the δ2 receptor agonist [D-Ala2, Glu4]deltorphin (DELT) was unable to reduce the evoked EPSP/EPSC by more than 50% at 100 μM, the highest concentration tested. At concentrations that reduced evoked EPSP/EPSCs by 40- 60%, neither DAMGO, DPDPE, nor DELT decreased the amplitude of the postsynaptic current produced by brief pressure ejection of (S)-α-amino-3- hydroxy-5-methyl-4-isoxazole-propionic acid, suggesting a presynaptic site of action of these opioid receptor agonists. Bath application of 200 nM naltriben (NTB), a δ2 receptor antagonist, competitively increased the EC75 of DELT by 15.3-fold, but did not antagonize either DPDPE or DAMGO. The EC75 of DELT was further increased by 169.7-fold in the presence of 1 μM NTB. However, this high concentration of NTB also increased the EC50 of DPDPE by about threefold in a non-competitive manner and antagonized DAMGO in a noncompetitive manner. In contrast, bath application of 33 or 100 nM 7- benzylidenenaltrexone (BNTX), a δ1 receptor antagonist, produced a concentration-dependent, noncompetitive antagonism of DPDPE, but did not antagonize DELT. A modest noncompetitive antagonism of DAMGO occurred in the presence of 100 nM BNTX. Bath application of 500 nM naloxone competitively antagonized DAMGO as well as DPDPE, increasing their EC50 values by 13.3- and 2.5-fold, respectively. These results provide the first electrophysiological demonstration of functional subtypes of the δ-opioid receptor in rat spinal cord and indicate that activation of either δ1- or δ2-opioid receptors inhibits excitatory, glutamatergic afferent transmission in the spinal cord. This effect may mediate the ability of δ1 or δ2 receptor agonists to produce antinociception when administered intrathecally in the rat.
AB - This study examined the electrophysiological consequences of selective activation of δ1-, δ2-, or μ-opioid receptors using whole-cell recordings made from visually identified lamina II neurons in thin transverse slices of young adult rat lumbar spinal cord. Excitatory postsynaptic currents (EPSCs) or potentials (EPSPs) were evoked electrically at the ipsilateral dorsal root entry zone after blocking inhibitory inputs with bicuculline and strychnine, and NMDA receptors with D-2-amino-5- phosphonopentanoic acid. Bath application of the μ receptor agonist [D- Ala2, N-MePhe4, Gly5-ol]enkephalin (DAMGO) or the δ1 receptor agonist [D-Pen2, D-Pen5]enkephalin (DPDPE) produced a log-linear, concentration- dependent reduction in the amplitude of the evoked EPSP/EPSC. By comparison, the δ2 receptor agonist [D-Ala2, Glu4]deltorphin (DELT) was unable to reduce the evoked EPSP/EPSC by more than 50% at 100 μM, the highest concentration tested. At concentrations that reduced evoked EPSP/EPSCs by 40- 60%, neither DAMGO, DPDPE, nor DELT decreased the amplitude of the postsynaptic current produced by brief pressure ejection of (S)-α-amino-3- hydroxy-5-methyl-4-isoxazole-propionic acid, suggesting a presynaptic site of action of these opioid receptor agonists. Bath application of 200 nM naltriben (NTB), a δ2 receptor antagonist, competitively increased the EC75 of DELT by 15.3-fold, but did not antagonize either DPDPE or DAMGO. The EC75 of DELT was further increased by 169.7-fold in the presence of 1 μM NTB. However, this high concentration of NTB also increased the EC50 of DPDPE by about threefold in a non-competitive manner and antagonized DAMGO in a noncompetitive manner. In contrast, bath application of 33 or 100 nM 7- benzylidenenaltrexone (BNTX), a δ1 receptor antagonist, produced a concentration-dependent, noncompetitive antagonism of DPDPE, but did not antagonize DELT. A modest noncompetitive antagonism of DAMGO occurred in the presence of 100 nM BNTX. Bath application of 500 nM naloxone competitively antagonized DAMGO as well as DPDPE, increasing their EC50 values by 13.3- and 2.5-fold, respectively. These results provide the first electrophysiological demonstration of functional subtypes of the δ-opioid receptor in rat spinal cord and indicate that activation of either δ1- or δ2-opioid receptors inhibits excitatory, glutamatergic afferent transmission in the spinal cord. This effect may mediate the ability of δ1 or δ2 receptor agonists to produce antinociception when administered intrathecally in the rat.
KW - 7-benzylidene-naltrexone (BNTX)
KW - DAMGO
KW - DPDPE
KW - EPSP
KW - deltorphin
KW - naloxone
KW - naltriben
KW - spinal cord slice
KW - δ-opioid receptor
UR - http://www.scopus.com/inward/record.url?scp=0028169755&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028169755&partnerID=8YFLogxK
U2 - 10.1523/jneurosci.14-08-04965.1994
DO - 10.1523/jneurosci.14-08-04965.1994
M3 - Article
C2 - 8046463
AN - SCOPUS:0028169755
SN - 0270-6474
VL - 14
SP - 4965
EP - 4971
JO - Journal of Neuroscience
JF - Journal of Neuroscience
IS - 8
ER -